Denali Therapeutics Inc Free Cash Flow Generation Index
Denali Therapeutics Inc free cash flow generation index. Denali Therapeutics Inc (DNLI) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $512.72 Million represents 1% of operating cash flow ($513.91 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Denali Therapeutics Inc (2018–2020)
Free cash flow generation index of Denali Therapeutics Inc from 2018 to 2020. Historical FCF Generation Index trend for Denali Therapeutics Inc across 2 annual periods. See Denali Therapeutics Inc (DNLI) flexibility index to measure the company's free cash flow as a share of total liabilities.
Denali Therapeutics Inc Free Cash Flow Generation Index by Year (2018–2020)
Denali Therapeutics Inc free cash flow generation index by year from 2018 to 2020. Year-by-year Free Cash Flow Generation Index for Denali Therapeutics Inc. For the full cash flow conversion analysis, see Denali Therapeutics Inc (DNLI) cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.99x | $413.06 Million | $416.15 Million | $3.10 Million | ▲ +6.5% |
| 2018 | 0.93x | $46.72 Million | $50.12 Million | $3.39 Million | — |